Moderna Inc logo

Moderna Inc

XTER:0QF (USA)  
€ 73.14 (-0.72%) Dec 5
At Loss
P/B:
2.26
Market Cap:
€ 27.55B ($ 29.65B)
Enterprise V:
€ 21.91B ($ 23.58B)
Volume:
1.22K
Avg Vol (2M):
5.11K
Also Trade In:
Volume:
1.22K
At Loss
Avg Vol (2M):
5.11K

Business Description

Description
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 5.21
Equity-to-Asset 0.69
Debt-to-Equity 0.11
Debt-to-EBITDA -0.8
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.48
Distress
Grey
Safe
Beneish M-Score -2.55
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 578.9
3-Year Book Growth Rate 142.3

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 62.52
9-Day RSI 55.67
14-Day RSI 49.23
6-1 Month Momentum % -41.38
12-1 Month Momentum % -57.24

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.46
Quick Ratio 2.35
Cash Ratio 1.73
Days Inventory 63.72
Days Sales Outstanding 58.55
Days Payable 25.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.6
Shareholder Yield % -0.59

Financials (Next Earnings Date:2024-02-23 Est.)

XTER:0QF's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Moderna Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 8,543.435
EPS (TTM) (€) -8.686
Beta 0
Volatility % 33.89
14-Day RSI 49.23
14-Day ATR (€) 3.044968
20-Day SMA (€) 70.3185
12-1 Month Momentum % -57.24
52-Week Range (€) 58.63 - 202.75
Shares Outstanding (Mil) 381.28

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Moderna Inc Filings

Filing Date Document Date Form
No Filing Data

Moderna Inc Stock Events

Event Date Price(€)
No Event Data

Moderna Inc Frequently Asked Questions

What is Moderna Inc(XTER:0QF)'s stock price today?
The current price of XTER:0QF is €73.14. The 52 week high of XTER:0QF is €202.75 and 52 week low is €58.63.
When is next earnings date of Moderna Inc(XTER:0QF)?
The next earnings date of Moderna Inc(XTER:0QF) is 2024-02-23 Est..
Does Moderna Inc(XTER:0QF) pay dividends? If so, how much?
Moderna Inc(XTER:0QF) does not pay dividend.

Press Release

Subject Date
No Press Release